Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study

Abstract Introduction Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the most common immune neuropathies leading to severe impairments in daily life. Current treatment options include intravenous immunoglobulins (IVIG), which are administered at intervals of 4–12 weeks. Determina...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Lars Masanneck, Jan Voth, Niklas Huntemann, Menekse Öztürk, Christina B. Schroeter, Tobias Ruck, Sven G. Meuth, Marc Pawlitzki
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2023-08-01
سلاسل:	Neurological Research and Practice
الموضوعات:	Clinical trial Digital health technology CIDP End-of-dose Smartwatch
الوصول للمادة أونلاين:	https://doi.org/10.1186/s42466-023-00267-3
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!